| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 113.89B | 106.86B | 98.54B | 85.42B | 85.02B | 92.75B |
| Gross Profit | 29.23B | 25.21B | 21.17B | 19.55B | 19.14B | 19.43B |
| EBITDA | 16.19B | 12.54B | 9.12B | 7.45B | 7.59B | 7.77B |
| Net Income | 9.96B | 8.50B | 5.35B | 4.08B | 4.50B | 4.92B |
Balance Sheet | ||||||
| Total Assets | 165.09B | 166.24B | 165.29B | 146.02B | 134.09B | 141.36B |
| Cash, Cash Equivalents and Short-Term Investments | 11.28B | 11.29B | 11.80B | 8.41B | 6.40B | 13.30B |
| Total Debt | 16.51B | 19.21B | 18.71B | 17.53B | 11.95B | 16.56B |
| Total Liabilities | 57.84B | 63.61B | 68.47B | 56.66B | 47.34B | 56.66B |
| Stockholders Equity | 107.24B | 102.62B | 96.82B | 89.35B | 86.74B | 84.69B |
Cash Flow | ||||||
| Free Cash Flow | 7.96B | 1.81B | 4.15B | 25.00M | 301.00M | -1.10B |
| Operating Cash Flow | 13.29B | 5.78B | 6.77B | 1.72B | 2.10B | 1.15B |
| Investing Cash Flow | -6.20B | -4.50B | -2.98B | -3.60B | -2.34B | -1.91B |
| Financing Cash Flow | -8.99B | -1.60B | -338.00M | 3.91B | -6.75B | 1.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥4.03T | 6.49 | 11.29% | 0.74% | 9.82% | 24.12% | |
78 Outperform | ¥107.15B | 7.80 | ― | 3.49% | 5.62% | 28.00% | |
74 Outperform | ¥4.05T | 16.15 | 7.85% | 1.69% | 4.61% | 5.75% | |
72 Outperform | ¥627.58B | 8.33 | 13.92% | 1.50% | 6.30% | -16.29% | |
66 Neutral | ¥1.44T | 10.37 | 11.29% | 3.00% | 5.48% | 33.67% | |
65 Neutral | ¥622.61B | 12.46 | 8.51% | 2.96% | -2.82% | -50.73% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |